Physician

Stephen Gerard Comeau, M.D.

According to 2025 Medicare claims, Stephen Comeau, M.D. (NPI: 1538165402) practices nephrology in the Bangor, ME market, with the plurality of this provider's patient population coming from Penobscot, ME. This provider's primary affiliated billing organization is NORTHEAST NEPHROLOGY PA (NPI: 1336145200; TIN: 01-0521643) and primary practice location at 04401-6614. Comeau is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), Community Care Partnership of Maine, LLC (ACO ID: A2831), and Beacon Rural Health, LLC (ACO ID: A5614), participating under the MSSP model.

Comeau's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 380 traditional Medicare patients, billed 1,226 HCPCS/CPT codes, and received $179,782 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 594 prescription claims across 144 beneficiaries totaling $138,301 in drug costs, led by Xphozah (Tenapanor Hcl). DME data shows 68 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $280,608 and ending at $179,782. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $296,292 to $138,301. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	732	2,766	$280,608
2016	672	2,050	$192,993
2017	559	1,851	$186,298
2018	578	1,769	$197,217
2019	581	1,823	$166,976
2020	575	1,783	$162,772
2021	539	1,682	$191,463
2022	442	1,454	$192,141
2023	396	1,597	$246,323
2024	380	1,226	$179,782

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	219	1,213	$296,292
2016	237	1,267	$712,671
2017	224	1,173	$431,982
2018	231	1,064	$316,029
2019	195	856	$184,583
2020	181	770	$158,066
2021	177	745	$149,507
2022	152	629	$124,668
2023	156	576	$124,894
2024	144	594	$138,301

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	238	$16,000
2016	N/R	186	$12,145
2017	N/R	186	$10,529
2018	N/R	135	$10,372
2019	N/R	154	$8,106
2020	N/R	158	$7,212
2021	N/R	66	$3,079
2022	N/R	103	$4,323
2023	N/R	80	$4,082
2024	N/R	68	$3,094

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	125	347	$259
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	76	134	$214
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	36	36	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	106	152	$78
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	100	284	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xphozah	Tenapanor Hcl	15	450	$39,296
Jardiance	Empagliflozin	16	1,067	$20,061
Farxiga	Dapagliflozin Propanediol	16	1,080	$18,908
Sevelamer Carbonate	Sevelamer Carbonate	42	2,691	$12,268
Lokelma	Sodium Zirconium Cyclosilicate	18	491	$6,897

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7515	Cyclosporine, oral, 25 mg	N	N/R	12	$2,019
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	19	$523
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	23	$288
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	14	$263

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Stephen Gerard Comeau, M.D.?

Tedicare shows public-source Medicare data for Stephen Gerard Comeau, M.D. (NPI 1538165402), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stephen Gerard Comeau, M.D. have ACO affiliation data?

Stephen Gerard Comeau, M.D. is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290), Community Care Partnership of Maine, LLC (MSSP, ACO ID A2831), and Beacon Rural Health, LLC (MSSP, ACO ID A5614).

What billing organization is linked to Stephen Gerard Comeau, M.D.?

Stephen Gerard Comeau, M.D. is linked to NORTHEAST NEPHROLOGY PA (billing NPI 1336145200) in the available physician profile data.

Does Stephen Gerard Comeau, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.